Collective Family Office LLC Sorrento Therapeutics, Inc. Transaction History

Collective Family Office LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 11, 2023	BUY	$0.74 - $1.83 $9,990 - $24,705	13,500 Added 12.75%	119,420 $0
Q3 2022 Oct 14, 2022	BUY	$1.51 - $2.88 $10,834 - $20,664	7,175 Added 7.27%	105,920 $166,000
Q2 2022 Jul 18, 2022	BUY	$1.24 - $2.33 $14,551 - $27,342	11,735 Added 13.49%	98,745 $198,000
Q1 2022 Apr 25, 2022	BUY	$2.0 - $4.9 $38,400 - $94,080	19,200 Added 28.31%	87,010 $203,000
Q4 2021 Jan 18, 2022	BUY	$4.65 - $7.23 $109,772 - $170,678	23,607 Added 53.41%	67,810 $315,000
Q3 2021 Oct 08, 2021	BUY	$7.41 - $10.99 $114,432 - $169,718	15,443 Added 53.7%	44,203 $337,000
Q2 2021 Jul 14, 2021	BUY	$6.35 - $10.0 $38,576 - $60,750	6,075 Added 26.78%	28,760 $279,000
Q1 2021 Apr 14, 2021	BUY	$7.03 - $16.51 $5,096 - $11,969	725 Added 3.3%	22,685 $188,000
Q4 2020 Feb 12, 2021	BUY	$5.76 - $11.95 $126,489 - $262,422	21,960 New	21,960 $150,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Collective Family Office LLC, based on Form 13F filings with the SEC.

Stay updated on Collective Family Office LLC with notifications on news.